“Nutex Health (NUTX) is aware of a short seller report issued on November 25, 2025 by Capybara Research. Based on publicly available information, Capybara Research as an entity seems not to exist. In the past, lawsuits filed against Capybara by other victims of its abusive tactics could not be served because the person or persons controlling Capybara have taken actions to conceal their identity and location. The sole purpose of this attack appears to be to create market confusion and to profit from the decline in trading price caused as a result. Unfortunately, this has become a common short seller tactic that many public companies have encountered. The allegations in the report appear to be insinuations based on either outdated, inapplicable, incomplete or wrong factual information. The company does not intend to comment further on this short seller report.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUTX:
- Capybara Research believes Nutex Health engaged in fraudulent business practices
- Clinigence Holdings Files Auditors’ Consent for Nutex
- Nutex Health Inc. Reports Strong Revenue Growth
- Nutex Health reports Q3 EPS $7.76 vs. ($1.72) last year
- Closing Bell Movers: Plug Power slips after converible notes offering